<DOC>
	<DOC>NCT02086474</DOC>
	<brief_summary>The objective of this study is to assess the changes in daily physical activity and gait pattern, following a viscosupplement injection among a population who is suffering from hip osteoarthritis. A kinetic and kinematic gait analysis, an Actigraph activity monitor, a functional Timed-Stair-Test and two questionnaires (Medical Outcome Study Short-Form36 (MOS-SF36), Hip disability and Osteoarthritis Outcome Score (HOOS)) about how the pathology affects the quality of life, will be use.</brief_summary>
	<brief_title>Daily Activity and Gait Analysis After Viscosupplement Injection Among Hip Osteoarthritis Patients</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Hip</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Viscosupplements</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>From 45 years old to 65 years old Clinically symptomatic moderate or severe hip osteoarthritis (TÃ¶nnis Grade II to III) Capacity to keep steady upright position and walking during 15 minutes Body mass index &lt; 40kg/m2 Bilateral hip osteoarthritis No broken hip or leg during the last 12 months Bone necrosis Rheumatoid arthritis, articular chondrocalcinosis, metabolic bone disease, psoriasis, gout, active infection Per os corticosteroid treatment Corticosteroid injection &lt; 3 months Viscosupplement injection &lt; 6 months Hypersensitivity to hyaluronic acid products Planed surgery during study duration Physical or mental disability to fill in questionnaires and/or to participate to followup</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>